Eric W. Dolan, writing for PsyPost:
In addition to reducing symptoms of depression, the psychedelic drug 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) appears to cause changes in inflammatory biomarkers, according to preliminary research published in the journal Psychopharmacology.
I’ve been hearing more and more about the potential anti-inflammatory indications of psychedelic drugs lately.